TD Securities analyst Tim James lowered the firm’s price target on Andlauer Healthcare (ANDHF) to C$53 from C$54 and keeps a Buy rating on the shares.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANDHF:
- Andlauer Healthcare Group Reports Stable 2024 Earnings
- Andlauer Healthcare Group Reports Stable 2024 Financial Results Amid Market Challenges
- Andlauer Healthcare price target raised to C$52 from C$50 at Stifel
- Andlauer Healthcare Group, Inc. (ANDHF) Q4 Earnings Cheat Sheet
- Andlauer Healthcare price target raised to C$49 from C$45 at National Bank